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Poor health-related quality of life in patients with
peripheral arterial disease: Type D personality
and severity of peripheral arterial disease as
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Background: Peripheral arterial disease (PAD) is associated with poor health-related quality of life (HRQOL), but
individual differences in this patient-based outcome are not fully understood. We examined the impact of PAD severity,
invasive treatment, and type D personality, defined as tendencies to experience negative emotions and be socially
inhibited, on HRQOL in a 1-year follow-up study.
Method: At their first visit to the department of surgery at the St. Elisabeth Hospital in Tilburg, The Netherlands, 203
consecutive PAD patients completed the DS14 type D personality and RAND-36 questionnaires (all self-report). Clinical
data were derived from patients’ medical files and included ankle-brachial index (ABI), initial and absolute claudication
distance (ICD, ACD), and invasive treatment. The main outcome was HRQOL at 1-year follow-up.
Results:HRQOL improved between baseline and follow-up, and invasive treatment led to significant improvements in the
subscales Physical Functioning (P .005) and Pain (P .003). Type D patients were severely impaired in their HRQOL
compared with other patients at baseline (P < .01) and at follow-up (P < .05). ABI and ACD also predicted HRQOL at
follow-up. After adjusting for ABI and ACD, invasive treatment and type D personality independently predicted all
HRQOL domains, except for Physical Functioning. Overall, type D personality predicted increased risk for both poor
General Health (odds ratio [OR], 3.70; 95% confidence interval [CI], 1.69 to 8.08; P  .001) and poor Mental Health
(OR, 6.01; 95% CI, 2.44 to 14.79, P < .0001) at 1 year after the PAD diagnosis.
Conclusion: Despite an overall improvement, type D patients remained more impaired in 1-year HRQOL than other
patients, adjusting for ABI and ACD. Type D personality is a psychologic risk factor that predicts poor patient-based
outcomes in PAD and should be taken into account when HRQOL in PAD is evaluated. (J Vasc Surg 2007;46:507-12.)Peripheral arterial disease (PAD) is associated with
cardiovascular mortality1 and impaired functioning.2,3 To
understand the impact of PAD and its treatment, it is
important to include patient-based measures in the evalu-
ation of care.4 Although indexes of disease severity such as
ankle-brachial index (ABI) and absolute claudication dis-
tance (ACD) may predict functional impairment in PAD
patients,3 they only partially determine patient-based out-
comes such as health-related quality of life (HRQOL).5-7
Invasive treatment of PAD may improve HRQOL.8 How-
ever, other factors associated withHRQOL in patients with
PAD are not fully understood,9 and the influence of sub-
group differences in PAD is not clear yet.
Age and sex have traditionally been included as individ-
ual difference variables in outcome research on PAD,10,11
but other variables may also affect the clinical course of
PAD. A potential individual difference variable in this con-
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doi:10.1016/j.jvs.2007.04.039text is the distressed personality type (type D); i.e. the
tendency to experience psychologic stress across time and
situations.12,13 The type D personality has been shown to
adversely affect the clinical course and HRQOL in cardiac
patients.12-14 Preliminary evidence from a cross-sectional
study including a combined sample of PAD patients and
healthy controls suggests that type D personality may be
associated with impaired QOL above and beyond the im-
pairment already related to having PAD.15 Hence, type D
personality is not merely a function of atherosclerotic vas-
cular disease, but it may represent a distinctly different risk
factor for poor patient-based outcomes.
Identifying which patients are susceptible to psycho-
logic problems may help in reducing adverse outcomes.
Prospective research on the influence of psychologic fac-
tors, such as type D personality, on HRQOL in PAD
patients is still lacking. Therefore, the aim of the present
prospective study was to evaluate the impact of disease
severity, invasive treatment of PAD, and type D personality
on patients’ HRQOL at 1-year follow-up.
METHODS
Patients. Between September 2001 and March 2004,
257 consecutive patients with PAD were referred to the
vascular outpatient clinic of the Department of Surgery at
the St. Elisabeth Hospital in Tilburg, The Netherlands. All
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tion from their history, physical examination, ABI, and
treadmill-walking distance, and visited the vascular surgeon
for the first time. Six patients were excluded from the study
because of cognitive impairment (n 2), recent myocardial
infarction, visual problems, illness (influenza), and partici-
pation in another study. Of the remaining 251 patients,
203 (81%) agreed to participate and completed two ques-
tionnaires on type D personality and HRQOL. No signifi-
cant differences were found in age, sex, ABI, ACD, initial
claudication distance (ICD), cardiovascular risk factors, or
comorbidity between participants and nonparticipants. The
mean age was 64.5 years, and 63% were men. During the
1-year follow-up period, four patients (2%) died and seven
were hospitalized for other reasons than invasive treatment
of PAD. To prevent confounding of the results, these
patients were excluded from follow-up analyses, leaving
192 patients for further analyses. After 1 year, the patients
were asked to complete the HRQOL questionnaire again
and 167 (87%) agreed. The study was approved by the
Ethics Committee of the St. Elisabeth Hospital, and all
patients signed informed consent.
Severity and invasive treatment of peripheral arte-
rial disease. The ICD, ACD, and ABI weremeasured in all
patients as indices of PAD severity. The ABI is defined as
the ratio of the ankle systolic blood pressure to the brachial
artery systolic blood pressure and has a normal range of 0.9
to 1.3. A value of 0.90 is 95% sensitive to detect PAD16,17
and has been shown to be a strong predictor of cardiovas-
cular disease and mortality.18 Treadmill-walking tests were
performed to determine ACD and ICD. Treadmill tests are
widely used to obtain objective information on walking
ability of patients with PAD.19
During the 1-year follow-up period, hospital admission
was examined using the patient records from the participat-
ing hospital. All patients who underwent invasive treatment
for PAD (either endovascular or surgical) were hospital-
ized. Invasive procedures were done in the St. Elisabeth
Hospital. Information for patients who had been admitted
to another hospital was obtained from the patient records.
Patients who were not hospitalized at all during the 1-year
follow-up period were considered to be event free.
Conservative treatment consisted of 3 months of unsu-
pervised exercise training, the advice to quit smoking, and
antiplatelet medication. All patients were followed up
throughout the study period for hospital admission. Pa-
tients were excluded from follow-up analyses if they were
hospitalized for other reasons than invasive treatment of
PAD, such as coronary artery bypass grafting.
According to The Society for Vascular Surgery (SVS)
and theNorthAmericanChapter of The International Society
for Cardiovascular Surgery (ISCVS), recommended stan-
dards,20 comorbid medical conditions diabetes mellitus,
smoking, hypertension, hyperlipidemia, and cardiac, ca-
rotid, renal and pulmonary disease were assessed at baseline
in all patients.
Type D personality. The 14-item Type D Scale-14
(DS14) was used to measure type D personality.21 Allquestions consist of a 5-point Likert-type scale (range, 0
to 4). The DS14 consists of two subscales that measure
negative affectivity (the tendency to experience negative
emotions) and social inhibition (the tendency to inhibit the
expression of emotions in social interaction). High scores
(10) on both scales indicate type D personality. Both
subscales have good reliability; Cronbach  is .88 and .86,
respectively.21 Type D personality is not mood-state de-
pendent but remains stable over time.21 In cardiac patients,
type D is an independent predictor of adverse outcomes.
The role of type D in PAD is not clear yet, however. In the
present study, type D personality was measured in all pa-
tients at baseline.
Health-related quality of life. HRQOL was mea-
sured at baseline and at 12 months of follow-up using the
36-item RAND-36 item health survey (RANDHealth Com-
munications, Santa Monica, Calif).22,23 The RAND-36 as-
sesses eight concepts: (1) Physical Functioning, (2) Social
Functioning, (3) role limitations due to physical problems
(Role-Physical); (4) role limitations due to emotional prob-
lems (Role-Emotional), (5)Mental Health, (6) Vitality, (7)
Bodily Pain, and (8) General Health Perception. The
RAND-36 has good reliability and validity.24
Statistical analyses. Differences between patients
were examined with 2 tests (dichotomous variables) and
the Student t tests (continuous variables). Analyses of
variance with repeated measures were used to compare
between-group differences (type D vs nontype D, and
invasive vs conservative treatment) over time on HRQOL.
ACD and ICD were included in a regression analysis to
determine which measure of walking distance was the best
predictor of HRQOL. Stepwise multiple regression analy-
ses were used to examine the influence of demographics
(block 1), PAD severity, invasive treatment, and comorbid-
ity (block 2), and type D personality (block 3) on the eight
HRQOL domains at the 1-year follow-up. Multivariate
logistic regression analyses (enter method) were conducted
to determine the impact of type D personality on poor
physical and psychologic HRQOL, adjusting for age, sex,
ABI and ACD. For this purpose, the RAND-36 domains
Mental Health and General Health were recoded into
discrete variables, and the lowest quartile indicated poor
HRQOL. All statistical analyses were performed with SPSS
12.0 software (SPSS Inc, Chicago, Ill).
RESULTS
Changes in health-related quality of life. Between
baseline and 1-year follow-up, there was an overall im-
provement in HRQOL. Patients experienced significant
improvements in Physical Functioning and Bodily Pain
(P  .0001); Social Functioning, Role-Physical, Role-
Emotional, and Vitality (P .01); andMental Health (P
.05). Scores for General Health, however, did not improve
significantly (P  .077).
During the follow-up period, 93 patients (48%) were
treated invasively for their PAD condition, and 99 patients
received conservative (noninvasive) treatment. Modes of
invasive treatment were percutaneous transluminal angio-
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or combinations of these interventions (24%). No amputa-
tions were required. Invasive treatment led to significant
improvements in HRQOL domains Physical Functioning
and Pain, as indicated by the significant interaction effects
for time  invasive treatment (P  .005 and P  .003,
respectively). Invasive treatment did not influence the other
aspects of HRQOL.
Type D personality and health-related quality of
life. Thirty-four percent of the PAD patients were classi-
fied as type D. No significant differences were noted be-
tween type D patients and the other PAD patients in
demographics, disease severity (ABI, ICD, ACD), cardio-
vascular risk factors, or comorbidity (Table I). Type D
patients were, however, more impaired in their HRQOL
than the other PAD patients at baseline (all P  .01; Fig 1).
At 1-year follow-up, HRQOL remained significantly
more impaired in type D patients compared with nontype
D patients (P .05), except for Physical Functioning (P
.454). The interaction effect for time  personality was
nonsignificant, indicating a stable adverse influence of type
D personality on HRQOL over time (Fig 1).
Predictors of health-related quality of life at 1-year
follow-up. Several baseline characteristics predicted HRQOL
at 1-year follow-up (Table II). With regard to disease severity,
a longer ACD was an independent predictor of better
HRQOL on all domains, whereas ABI predicted Mental
Health, Vitality, and General Health. In addition, invasive
treatment for PAD was an independent predictor of the
HRQOL domain Bodily Pain. Patients who were treated
invasively for their PAD reported less pain than patients
with conservative treatment (Table II).
After adjusting for all demographic and clinical vari-
Table I. Baseline characteristics of the 203 patients
who agreed to participate in the study, stratified by
type D personality
Characteristics*
Type D, % Nontype D, %
P(n  69, 34%) (n  134, 66%)
Demographics
Age 62.7  9.9 65.5  9.8 .060
Male sex 60 66 .400
Disease severity
Ankle-brachial index 0.65  0.16 0.61  0.16 .098
Claudication distance
Initial (meters) 101  87 122  165 .329
Absolute (meters) 345.4  289 385  338 .417
Clinical factors
Diabetes mellitus 23 18 .437
Tobacco use 62 49 .084
Hypertension 49 43 .390
Hyperlipidemia 55 52 .649
Cardiac disease 35 28 .299
Carotid disease 13 8 .263
Renal disease 6 3 .388
Pulmonary disease 7 9 .700
*Categoric data are presented as percentages; continuous data are presented
as mean  standard deviation.ables, type D personality remained as an independent pre-dictor of seven of eight HRQOL domains (Table II). In
general, type D patients had significantly poorer HRQOL
than other patients (Table II). Both disease severity and
type D personality independently predicted the 1-year level
of Social Functioning, Role-Physical, Mental Health, Vital-
ity, and General Health Perception. Invasive treatment or
the presence of risk factors did not influence theseHRQOL
domains. However, Bodily Pain was affected by a combi-
nation of predictors, consisting of PAD severity, invasive
treatment, comorbidity, and type D personality.
Type D and impaired health-related quality of life
at 1-year follow-up. We then examined which subgroup
of patients was at increased risk of poor physical and psy-
chologic HRQOL. Of note, 46% (26/57) of type D pa-
tients experienced a poor General Health versus only 18%
(20/110) of the nontypeD patients (P .0001). Likewise,
42% (24/57) of the type D patients had a poor Mental
Health score at follow-up vs 11% (12/110) of the nontype
D patients (P  .0001). Multivariate logistic regression
analyses showed that type D PAD patients were at a sub-
stantially increased risk for both poor General Health (odds
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Fig. Health-related quality of life at baseline and at 1-year fol-
low-up stratified by typeD personality (solid circles) and nontypeD
personality (open squares). Univariate analysis was by analysis of
variance for repeated measures. A higher score indicates better
health status, with a high score on Bodily Pain representing the
absence of pain.ratio [OR], 3.70; 95% confidence interval [CI], 1.69 to
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CI, 2.44 to 14.79; P  .0001) after adjusting for demo-
graphics and disease severity (Table III).
DISCUSSION
Patients who were treated invasively for PAD improved
in their physical functioning and pain. However, despite a
general improvement in HRQOL, type D patients still had
Table II. Predictors of health-related quality of life at 1-y
RAND-36 Domains Predictors
Physical Functioning ACD
Social Functioning ACD
Type D personality
Role-Physical Problems ACD
Type D personality
Role-Emotional Problems ACD
Pulmonary disease
Type D personality
Mental Health ABI
ACD
Type D personality
Vitality ABI
ACD
Type D personality
Bodily Pain ACD
Hypertension
Carotid disease
Invasive treatment
Type D personality
General Health Perception ABI
ACD
Type D personality
ACD, Absolute claudication distance; ABI, ankle-brachial index.
*Analysis based on stepwise multivariate regression analyses with demograph
type D personality as block 3.
†Significant at P  .01.
‡Significant at P  .001.
Table III. Independent predictors of impaired health-
related quality of life using multivariate logistic
regression analysis
Impaired
HRQOL
Multivariate
predictors OR 95% CI P
Poor general
health
Age* 1.02 0.97-1.06 .444
Male sex 2.12 0.90-5.01 .087
ABI* 1.03 1.00-1.06 .045
ACD† 0.77 0.65-0.92 .003
Type D personality 3.65 1.67-7.98 .001
Poor mental
health
Age* 0.99 0.95-1.04 .742
Male sex 0.75 0.29-1.91 .545
ABI* 1.01 0.98-1.05 .379
ACD† 0.83 0.69-0.99 .046
Type D personality 5.97 2.43-14.71 .0001
HRQOL, Health-related quality of life; OR, odds ratio; CI, confidence
interval; ABI, ankle-brachial index; ACD, absolute claudication distance.
*Age and ankle-brachial index were entered as continuous variables.
†Absolute claudication distance was entered as a discrete variable with
increasing intervals of 100 meters.a significantly poorer HRQOL after 1 year of follow-up.Accordingly, invasive treatment (positively) and type D
personality (negatively) were both independent predictors
of HRQOL, adjusting for ABI, ACD, and comorbidity.
HRQOL has become an important patient-based out-
come measure in cardiovascular research.25,26 Impaired
HRQOL has been shown to be an independent predictor
of mortality and hospitalization in cardiac patients.26-28
Similarly, our previous research in another sample of PAD
patients showed that impaired HRQOL predicted invasive
treatment in these patients.29 However, most of the cardio-
vascular research on HRQOL has been conducted in pa-
tients with coronary artery disease or heart failure. Less is
known about HRQOL in PAD patients and the way treat-
ment affects this important patient-based outcome, even
though these patients undergo many procedures. There-
fore, identifying PAD patients at increased risk of poor
HRQOL is very important.
The results of the present study confirm previous ob-
servations that walking-induced pain is associated with
severe impairments in HRQOL.7,30 We found that ACD
independently predicted HRQOL, in that patients who
were less impaired in their walking distance reported better
HRQOL. Consistent with our previous findings in another
sample of PAD patients, invasive treatment did improve
HRQOL in the present study29; however, these treatment-
related improvements in Physical Functioning and Bodily
Pain did not affect the other HRQOL domains. Hence,
invasive treatment of PAD is associated with improvements
in physical HRQOL, but other factors that may influence
llow-up*
R2 Standardized B F
0.246 0.265 2.73†
0.263
0.242 –0.367 3.24‡
0.280
0.271 –0.287 3.48‡
0.203
–0.224
0.200 –0.240 2.40†
–0.188
0.212
0.274 –0.404 3.75‡
–0.167
0.329
0.276 –0.359 3.83‡
0.289
–0.215
–0.210
0.215
0.276 –0.160 3.82‡
–0.288
0.331
0.330 –0.303 4.90‡
block 1; disease severity, risk factors, and invasive treatment as block 2; andear fo
ics asHRQOL are not fully understood.9
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subgroups of PAD patients. Traditionally, age and sex have
been included in research on PAD.10,11 Women with PAD
may have greater walking impairment, a higher prevalence
of leg pain, and poorer functioning than men with PAD,10
and PAD severity has been associated with QOL among
older patients.11 In the present study, age and sex were not
statistically significantly related to HRQOL at follow-up.
However, other individual difference variables may affect
the clinical course of PAD patients.
We found that type D personality had a major effect on
HRQOL in PAD. This is in line with previous studies
showing that type D predicted poor HRQOL and QOL
after invasive treatment, including coronary artery bypass
surgery,31 percutaneous coronary intervention,32 and heart
transplantation.33 This adverse type D effect was also ob-
served in cardiac rehabilitation12 and heart failure pa-
tients.34 Of importance are the findings of the present study
that indicate the predictive value of type D personality
regarding poor HRQOL in PAD over time. Type D pa-
tients reported significantly poorer HRQOL than nontype
D patients across both baseline and follow-up assessments,
and despite the relative improvement in HRQOL over
time, type D patients still had a significantly impaired
HRQOL at 1-year follow-up compared with the other
patients.
This study has some limitations. First, patients with
ischemic rest pain or tissue loss were not included. By
including patients with critical limb ischemia, a more het-
erogeneous patient group could be obtained, possibly lead-
ing to a larger effect of ABI on HRQOL.
Second, 1 year may be a relatively short period to
evaluate changes in HRQOL. However, the effect of type
D personality on HRQOL was stable and in accordance
with previous studies that used follow-up periods of 5 to 10
years.12,35
Third, we did not assess type D personality at 1-year
follow-up. Although type D remains stable over time in
cardiac patients,21 future studies should look at the stability
of type D in PAD.
Finally, ABI and walking impairment were not exam-
ined at follow-up. Future research should examine the
relationship between patient-based outcomes and clinical
improvement after treatment.
CONCLUSION
The findings of the present study have implications for
further clinical research and practice. Recent guide-
lines17,25 emphasize the importance of assessing outcomes
from the patient’s perspective. It is also argued that infor-
mation on HRQOL should be included in treatment
policy.36 The findings from the present study support this
notion. Type-D patients had poorer HRQOL both at
baseline and at 1-year follow-up. When evaluating out-
comes such as HRQOL in the management of PAD, it is
important not only to examine the total patient group but
also to look at specific subgroups of patients. Type D
personality should be accounted for in addition to age andsex to examine individual differences between patients.
Identifying high-risk patients and providing more accurate
treatment options for these patients, may help to improve
their HRQOL.
These findings demonstrate the need to study risk
factors that may predict poor HRQOL in patients with
PAD in addition to indices of disease severity and invasive
treatment. Despite the general improvement in HRQOL,
type D patients remained more impaired in their HRQOL
than nontypeD patients, indicating the stable adverse effect
of type D on HRQOL over time. Personality should be
included when evaluating HRQOL in PAD. Hence, the
present study provides evidence for the predictive value of
type D personality in addition to traditional clinical indica-
tors and invasive treatment with regard to HRQOL
in PAD.
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